Safety and Efficacy Study of BRIMOCHOL™ PF and Carbachol PF in Subjects With Emmetropic Phakic and Pseudophakic Presbyopia

PHASE3CompletedINTERVENTIONAL
Enrollment

629

Participants

Timeline

Start Date

March 15, 2022

Primary Completion Date

March 13, 2025

Study Completion Date

March 13, 2025

Conditions
Presbyopia
Interventions
DRUG

BRIMOCHOL™ PF

A single drop in each eye at a visit.

DRUG

Carbachol PF

A single drop in each eye at a visit.

DRUG

Vehicle

A single drop in each eye at a visit.

Trial Locations (42)

12603

Visus Therapeutics Investigative Site, Poughkeepsie

16066

Visus Therapeutics Investigative Site, Cranberry Township

18702

Visus Therapeutics Investigative Site, Wilkes-Barre

22046

Visus Therapeutics Investigative Site, Falls Church

24502

Visus Therapeutics Investigative Site, Lynchburg

27529

Visus Therapeutics Investigative Site, Garner

32256

Visus Therapeutics Investigative Site, Jacksonville

32757

Visus Therapeutics Investigative Site, Mt. Dora

33309

Visus Therapeutics Investigative Site, Fort Lauderdale

33484

Visus Therapeutics Investigative Site, Delray Beach

33770

Visus Therapeutics Investigative Site, Largo

34429

Visus Therapeutics Investigative Site, Crystal River

37167

Visus Therapeutics Investigative Site, Smyrna

37803

Visus Therapeutics Investigative Site, Maryville

38119

Visus Therapeutics Investigative Site, Memphis

40206

Visus Therapeutics Investigative Site, Louisville

43065

Visus Therapeutics Investigative Site, Powell

46260

Visus Therapeutics Investigative Site, Indianapolis

55420

Visus Therapeutics Investigative Site, Bloomington

57108

Visus Therapeutics Investigative Site, Sioux Falls

58078

Visus Therapeutics Investigative Site, West Fargo

60046

Visus Therapeutics Investigative Site, Lake Villa

63128

Visus Therapeutics Investigative Site, St Louis

64111

Visus Therapeutics Investigative Site, Kansas City

76054

Visus Therapeutics Investigative Site, Hurst

78229

Visus Therapeutics Investigative Site, San Antonio

78738

Visus Therapeutics Investigative Site, Lakeway

80120

Visus Therapeutics Investigative Site, Littleton

84020

Visus Therapeutics Investigative Site, Draper

85032

Visus Therapeutics Investigative Site, Phoenix

85224

Visus Therapeutics Investigative Site, Chandler

85351

Visus Therapeutics Investigative Site, Sun City

89502

Visus Therapeutics Investigative Site, Henderson

90301

Visus Therapeutics Investigative Site, Inglewood

91107

Visus Therapeutics Investigative Site, Pasadena

91204

Visus Therapeutics Investigative Site, Glendale

91345

Visus Therapeutics Investigative Site, Mission Hills

92604

Visus Therapeutics Investigative Site, Irvine

92663

Visus Therapeutics Investigative Site, Newport Beach

93105

Visus Therapeutics Investigative Site, Santa Barbara

97210

Visus Therapeutics Investigative Site, Portland

06810

Visus Therapeutics Investigative Site, Danbury

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Visus Therapeutics

OTHER

NCT05135286 - Safety and Efficacy Study of BRIMOCHOL™ PF and Carbachol PF in Subjects With Emmetropic Phakic and Pseudophakic Presbyopia | Biotech Hunter | Biotech Hunter